Tenax Therapeutics TENX
NASDAQ TENX
$1.75 -0.03 (-1.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Net Margin Growth (1y) (2012 - 2013)

Tenax Therapeutics (TENX) Net Margin Growth (1y) (2012 - 2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -763.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 529.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 4,168.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 673.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 2,208.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -1,652.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 29,636.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -392.00
10 Tenax Therapeutics 78.47 Mn 78.47 Mn - -

Historic Data

Download Data
DateValue
Apr 30, 2013 488,492.00
Jan 31, 2013 691,888.00
Oct 31, 2012 660,460.00
Jul 31, 2012 1.29 Mn
Apr 30, 2012 -917,777.00